All In Biotech

Drug Trial Radar · NCT00325195

Safety and Efficacy Study of PEG-uricase in the Treatment of Hyperuricemic Patients With Symptomatic Gout

Randomized, Multicenter, Double-blind, Placebo-controlled Efficacy and Safety Study of 8 mg PEG-uricase in Two Dose Regimens in Hyperuricemic Subjects With Symptomatic Gout

Last checked: Nov 20, 2026Latest source record: Feb 28, 2011 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingPhase 3. Randomized with 225 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

225

Actual

Start

May 2006

Primary completion

Oct 2007

Study completion Dec 2007

Sponsor

Lead sponsor
Savient PharmaceuticalsIndustry
Sponsor type
Industry
First posted
May 12, 2006

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

These are two replicate studies to evaluate the safety and efficacy of PEG (polyethylene glycol)-uricase in controlling the uric acid level in symptomatic gout patients with high uric acid levels who are unable to take standard gout therapies, or for whom those therapies have been unsuccessful in controlling their uric acid level.

Conditions

  • Gout

Interventions

  • placeboOther

    placebo by intravenous infusion every 2 weeks

  • pegloticaseBiological

    8 mg pegloticase by intravenous infusion

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Plasma Uric Acid (PUA) ResponderTime frame: Months 3 and 6

Locations

56 sites in 3 countries. Site status is shown where the registry gives one.

  • UAB Arthritis Clinical Intervention Program

    Birmingham, Alabama

  • University of Arizona Arthritis Center

    Tucson, Arizona

  • NEA Clinic

    Jonesboro, Arkansas

  • UCSD Rheumatology Division

    La Jolla, California

  • Kaiser Permanente Medical Center, Clinical Trials Unit

    San Francisco, California

  • Pacific Arthritis Center Medical Group

    Santa Maria, California

  • E. Robert Harris Medical Corporation

    Whittier, California

  • Agilence Arthritis & Osteoporosis Medical Center

    Whittier, California

  • Arthritis Associates & Osteoporosis Center of Colorado Springs

    Colorado Springs, Colorado

  • Veterans Affairs Medical Center

    Washington D.C., District of Columbia

  • Arthritis & Rheumatic Disease Specialties

    Aventura, Florida

  • Malcom Randall VA Medical Center

    Gainesville, Florida

  • Horizon Institute for Clinical Research

    Hollywood, Florida

  • Ocala Rheumatology Research Center

    Ocala, Florida

  • Arthritis & Osteoporosis Treatment Center, PA

    Orange Park, Florida

  • St. Petersburg Arthritis Center

    St. Petersburg, Florida

  • Idaho Arthritis & Osteoporosis Center

    Boise, Idaho

  • Institute of Arthritis Research

    Idaho Falls, Idaho

  • The University of Chicago

    Chicago, Illinois

  • Graves Gilbert Clinic

    Bowling Green, Kentucky

  • Peter A. Holt, M.D.

    Baltimore, Maryland

  • Malamet & Klein, MD, PA

    Hagerstown, Maryland

  • The Center for Rheumatology and Bone Research

    Wheaton, Maryland

  • Fallon Clinic, Inc

    Worcester, Massachusetts

  • Michigan Arthritis Research Center

    Brighton, Michigan

  • Justus J. Fiechtner, MD, PC

    Lansing, Michigan

  • Mayo Clinic

    Rochester, Minnesota

  • CentraCare Clinic

    Saint Cloud, Minnesota

  • Rheumatology Associates of North Jersey

    Teaneck, New Jersey

  • Mount Sinai Medical Center

    New York, New York

  • Duke University Medical Center

    Durham, North Carolina

  • Brody School of Medicine, East Carolina University

    Greenville, North Carolina

  • Physicians East, P.A.

    Greenville, North Carolina

  • Carolina Atthritis Associates

    Wilmington, North Carolina

  • New Horizons Clinical Research

    Cincinnati, Ohio

  • The Cleveland Clinic Foundation

    Cleveland, Ohio

  • The Ohio State University

    Columbus, Ohio

  • STAT Research, Inc.

    Dayton, Ohio

  • David R. Mandel, MD, Inc.

    Mayfield Village, Ohio

  • Health Research of Oklahoma

    Oklahoma City, Oklahoma

Showing 40 of 56 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.